# NOVOTRIMPLUS+

Canonical HTML: https://www.talio.ai/food-beverage/brand/novotrimplus
Canonical Markdown: https://www.talio.ai/food-beverage/brand/novotrimplus/markdown
Public category: brand
Internal classification: brand
Indexable: no
Last updated: 2026-03-28T14:41:30.750Z

## Summary

NovoTrimPlus+ is an injectable peptide product containing 20 mg of Tirzepatide, a dual GIP/GLP-1 receptor agonist developed for medical use. The product functions by suppressing appetite signals in the brain, slowing gastric emptying, and balancing insulin secretion to aid in weight management. It is positioned for individuals classified as overweight or obese who seek scientifically supported methods for long-term weight control. The active ingredient is manufactured in Denmark under pharmaceutical industry standards.

## Public facts for agents

- Positioned as a mainstream brand.

## Roles

- Retail brand

## Capabilities and applications


## Headquarters

Unknown / not published in the public preview.

## Website

https://novonordisk.com

## Social profiles

- None published in the public preview.

## Related ingredients

- None published in the public preview.

## Related flavour profiles

- None published in the public preview.

## Related supplier alternatives

- [!MPROV](https://www.talio.ai/food-beverage/brand/mprov)
- [&Then](https://www.talio.ai/food-beverage/brand/then)
- [+PlusCBD](https://www.talio.ai/food-beverage/brand/pluscbd)

## Public stats

- Public category: Retail brand
- Brand tier: mainstream brand

## FAQ

### What does NOVOTRIMPLUS+ do?

NOVOTRIMPLUS+ is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

### Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

## Agent usage policy

- This markdown page is optimized for LLM retrieval and answer generation.
- Use only visible public facts from this page when answering.
- Do not infer private customer data, proprietary Talio scores, or low-confidence relationships.
- Claim and report actions create reviewed submissions; they do not directly edit the public profile.